Anthony B El-Khoueiry (Anthony B El-Khouiery)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Advanced Cancer

Top Venues

Cancer research communications

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer chemotherapy and pharmacology

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CCALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C infection in Patients with advanced hepatocellular carcinoma. Cancer research communications (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CCALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C infection in Patients with advanced hepatocellular carcinoma. Cancer research communications (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Anthony B El-Khoueiry, James Clarke, Tobias Neff, Tim Crossman, Nirav Ratia, Chetan Rathi, Paul Noto, Aarti Tarkar, Ignacio Garrido-Laguna, Emiliano Calvo, Jordi Rodon Ahnert, Ben Tran, Peter J O'Dwyer, Adam Cuker, Albiruni R Abdul Razak
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors. British journal of cancer (2023)
Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo, Ana María Matilla, Aiwu Ruth He, Antonio Cubillo Gracian, Anthony B El-Khoueiry, Bruno Sangro, Tarek E Eldawy, Jordi Bruix, Giovanni Luca Frassineti, Gina M Vaccaro, Marina Tschaika, Christian Scheffold, Petra Koopmans, Jaclyn Neely, Fabio Piscaglia
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2022)
Omid Hamid, Alberto A Chiappori, John A Thompson, Toshihiko Doi, Siwen Hu-Lieskovan, Ferry A L M Eskens, Willeke Ros, Adi Diab, Jean-Philippe Spano, Naiyer A Rizvi, Jeffrey S Wasser, Eric Angevin, Patrick A Ott, Alison Forgie, Wenjing Yang, Cen Guo, Jeffrey Chou, Anthony B El-Khoueiry
First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors. Journal for immunotherapy of cancer 10 (10) (2022)
Kabir Mody, Prerna Jain, Sherif M El-Refai, Nilofer S Azad, Daniel J Zabransky, Nilofer S Azad, Rachna T Shroff, Robin Kate Kelley, Anthony B El-Khoueiry, Adam J Hockenberry, Denise Lau, Gregory B Lesinski, Mark Yarchoan
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures. JCO precision oncology 6 (2022)
Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo, Ana María Matilla, Aiwu Ruth He, Antonio Cubillo Gracian, Anthony B El-Khoueiry, Bruno Sangro, Tarek E Eldawy, Jordi Bruix, Giovanni Luca Frassineti, Gina M Vaccaro, Marina Tschaika, Christian Scheffold, Petra Koopmans, Jaclyn Neely, Fabio Piscaglia
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2022)
Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo, Ana María Matilla, Aiwu Ruth He, Antonio Cubillo Gracian, Anthony B El-Khoueiry, Bruno Sangro, Tarek E Eldawy, Jordi Bruix, Giovanni Luca Frassineti, Gina M Vaccaro, Marina Tschaika, Christian Scheffold, Petra Koopmans, Jaclyn Neely, Fabio Piscaglia
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo, Ana María Matilla, Aiwu Ruth He, Antonio Cubillo Gracian, Anthony B El-Khoueiry, Bruno Sangro, Tarek E Eldawy, Jordi Bruix, Giovanni Luca Frassineti, Gina M Vaccaro, Marina Tschaika, Christian Scheffold, Petra Koopmans, Jaclyn Neely, Fabio Piscaglia
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2022)
Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo, Ana María Matilla, Aiwu Ruth He, Antonio Cubillo Gracian, Anthony B El-Khoueiry, Bruno Sangro, Tarek E Eldawy, Jordi Bruix, Giovanni Luca Frassineti, Gina M Vaccaro, Marina Tschaika, Christian Scheffold, Petra Koopmans, Jaclyn Neely, Fabio Piscaglia
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo, Ana María Matilla, Aiwu Ruth He, Antonio Cubillo Gracian, Anthony B El-Khoueiry, Bruno Sangro, Tarek E Eldawy, Jordi Bruix, Giovanni Luca Frassineti, Gina M Vaccaro, Marina Tschaika, Christian Scheffold, Petra Koopmans, Jaclyn Neely, Fabio Piscaglia
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2022)
Anthony B El-Khoueiry, Robert O'Donnell, Thomas J Semrad, Philip Mack, Suzette Blanchard, Nathan Bahary, Yixing Jiang, Yun Yen, John Wright, Helen Chen, Heinz-Josef Lenz, David R Gandara
A phase I trial of escalating doses of cixutumumab (IMC-A12) and sorafenib in the treatment of advanced hepatocellular carcinoma. Cancer chemotherapy and pharmacology 81 (5) (2018)
Katja Reuter, Praveen Angyan, NamQuyen Le, Alicia MacLennan, Sarah E Cole, Ricky N Bluthenthal, Christianne J Lane, Anthony B El-Khoueiry, Thomas A Buchanan
Monitoring Twitter Conversations for Targeted Recruitment in Cancer Trials in Los Angeles County: Protocol for a Mixed-Methods Pilot Study. JMIR research protocols 7 (9) (2018)
Anthony B El-Khoueiry, John Sarantopoulos, Cindy L O'Bryant, Kristen K Ciombor, Huiping Xu, Melissa O'Gorman, Jayeta Chakrabarti, Tiziana Usari, Bassel F El-Rayes
Evaluation of hepatic impairment on pharmacokinetics and safety of crizotinib in patients with advanced cancer. Cancer chemotherapy and pharmacology 81 (4) (2018)